JP2014523906A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014523906A5 JP2014523906A5 JP2014519502A JP2014519502A JP2014523906A5 JP 2014523906 A5 JP2014523906 A5 JP 2014523906A5 JP 2014519502 A JP2014519502 A JP 2014519502A JP 2014519502 A JP2014519502 A JP 2014519502A JP 2014523906 A5 JP2014523906 A5 JP 2014523906A5
- Authority
- JP
- Japan
- Prior art keywords
- administered
- drug
- defensins
- agent
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11173351 | 2011-07-08 | ||
| EP11173351.5 | 2011-07-08 | ||
| US201161506437P | 2011-07-11 | 2011-07-11 | |
| US61/506,437 | 2011-07-11 | ||
| PCT/EP2012/063137 WO2013007596A2 (en) | 2011-07-08 | 2012-07-05 | Oral treatment of inflammatory bowel disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017008251A Division JP6251827B2 (ja) | 2011-07-08 | 2017-01-20 | 炎症性腸疾患の経口治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014523906A JP2014523906A (ja) | 2014-09-18 |
| JP2014523906A5 true JP2014523906A5 (enExample) | 2015-08-20 |
| JP6219277B2 JP6219277B2 (ja) | 2017-10-25 |
Family
ID=47506622
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014519502A Expired - Fee Related JP6219277B2 (ja) | 2011-07-08 | 2012-07-05 | 炎症性腸疾患の経口治療 |
| JP2017008251A Expired - Fee Related JP6251827B2 (ja) | 2011-07-08 | 2017-01-20 | 炎症性腸疾患の経口治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017008251A Expired - Fee Related JP6251827B2 (ja) | 2011-07-08 | 2017-01-20 | 炎症性腸疾患の経口治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US9217021B2 (enExample) |
| EP (1) | EP2729159B1 (enExample) |
| JP (2) | JP6219277B2 (enExample) |
| ES (1) | ES2637286T3 (enExample) |
| WO (1) | WO2013007596A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102159233A (zh) | 2008-07-18 | 2011-08-17 | 诺维信阿德宁生物技术公司 | 使用哺乳动物β防御素的炎性肠病的治疗 |
| JP6219277B2 (ja) | 2011-07-08 | 2017-10-25 | ディフェンシン セラピューティクス アンパルトセルスカブＤｅｆｅｎｓｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ａｐｓ | 炎症性腸疾患の経口治療 |
| KR101590452B1 (ko) | 2015-05-20 | 2016-02-02 | 중앙대학교 산학협력단 | 펩타이드 defb124를 유효성분으로 포함하는 면역증강 및 암 예방 또는 치료용 약학적 조성물 |
| US20170035845A1 (en) * | 2015-08-07 | 2017-02-09 | The Regents Of The University Of California | Compositions and Methods for Inhibiting Pro-Inflammatory Cytokine Gene Expression |
| ES2871117T3 (es) * | 2016-01-26 | 2021-10-28 | Defensin Therapeutics Aps | Procedimientos para modular la microbiota intestinal |
| PL3448409T3 (pl) * | 2016-04-29 | 2026-02-23 | Defensin Therapeutics Aps | Leczenie chorób wątroby, dróg żółciowych i trzustki defensynami |
| JP7129912B2 (ja) * | 2016-12-07 | 2022-09-02 | 株式会社ステリック再生医科学研究所 | 慢性疾患の治療及び予防用医薬組成物 |
| CA3045079A1 (en) | 2016-12-13 | 2018-06-21 | Defensin Therapeutics Aps | Methods for treating inflammatory conditions of the lungs |
| KR20200095472A (ko) * | 2017-11-10 | 2020-08-10 | 디펜신 테라퓨틱스 에이피에스 | 조산아에서의 점막 방어 및 장/폐 기능의 성숙화 |
| KR20200097251A (ko) * | 2017-11-24 | 2020-08-18 | 디펜신 테라퓨틱스 에이피에스 | 디펜신에 의한 이식편 대 숙주 질환의 예방 및 치료 |
| KR102244161B1 (ko) | 2018-08-31 | 2021-04-26 | 주식회사 나이벡 | 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도 |
| KR102742007B1 (ko) * | 2018-10-09 | 2024-12-12 | 유니버시티 오브 서던 캘리포니아 | 양이온성 마크로사이클릭 펩티드의 전신 전달성, 내약성, 및 효능을 향상시키기 위한 조성물 및 방법(compositions and methods for enhancing systemic deliverability, tolerability, and efficacy of cationic macrocyclic peptides) |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| DE4343591A1 (de) | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| DE19824484A1 (de) * | 1998-06-02 | 1999-12-09 | Bayer Ag | Festkörperreiche Polyurethandispersionen mit hoher Applikationssicherheit |
| DE19957043A1 (de) | 1999-11-26 | 2001-06-07 | Forssmann Wolf Georg | Neue Defensine |
| US7338936B2 (en) | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| US20080194481A1 (en) | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
| FR2841556B1 (fr) | 2002-07-01 | 2007-07-20 | Centre Nat Rech Scient | Peptides ayant des proprietes antimicrobiennes et les compositions les contenant notamment pour la conservation des aliments |
| US20060115480A1 (en) | 2002-12-19 | 2006-06-01 | Yitzchak Hillman | Disease treatment via antimicrobial peptide inhibitors |
| US20070207209A1 (en) | 2004-08-27 | 2007-09-06 | Murphy Christopher J | Trophic factor combinations for nervous system treatment |
| GB0514482D0 (en) | 2005-07-14 | 2005-08-17 | Ares Trading Sa | Protein |
| WO2007081486A2 (en) | 2005-12-15 | 2007-07-19 | Ventria Bioscience | Oral administration of defensins to treat intestinal diseases |
| WO2007087557A2 (en) | 2006-01-24 | 2007-08-02 | University Of Maryland Biotechnology Institute | Surface-layer protein coated microspheres and uses thereof |
| WO2009046833A1 (en) | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| MX2011000569A (es) | 2008-07-18 | 2011-02-23 | Novozymes Adenium Biotech As | Tratamiento de enfermedades inflamatorias con beta-defensinas de mamifero. |
| CN102159233A (zh) | 2008-07-18 | 2011-08-17 | 诺维信阿德宁生物技术公司 | 使用哺乳动物β防御素的炎性肠病的治疗 |
| MX2011000567A (es) | 2008-07-18 | 2011-02-23 | Novozymes Adenium Biotech As | Tratamiento de artritis reumatoide con beta-defensinas de mamifero. |
| DK2343292T3 (da) * | 2008-09-10 | 2014-11-03 | Asahi Glass Co Ltd | Nyt prostaglandin 12-derivat |
| JP2011121887A (ja) * | 2009-12-09 | 2011-06-23 | En Otsuka Pharmaceutical Co Ltd | 炎症性腸疾患用アミノ酸組成物 |
| JP4620169B1 (ja) | 2010-01-28 | 2011-01-26 | 株式会社三和化学研究所 | 有機酸重合体を有効成分とするクローン病の予防又は治療剤 |
| JP6219277B2 (ja) | 2011-07-08 | 2017-10-25 | ディフェンシン セラピューティクス アンパルトセルスカブＤｅｆｅｎｓｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ａｐｓ | 炎症性腸疾患の経口治療 |
| WO2013026794A1 (en) | 2011-08-19 | 2013-02-28 | Novozymes | Novel immunomodulatory peptide |
-
2012
- 2012-07-05 JP JP2014519502A patent/JP6219277B2/ja not_active Expired - Fee Related
- 2012-07-05 WO PCT/EP2012/063137 patent/WO2013007596A2/en not_active Ceased
- 2012-07-05 EP EP12746034.3A patent/EP2729159B1/en active Active
- 2012-07-05 ES ES12746034.3T patent/ES2637286T3/es active Active
- 2012-07-05 US US14/131,364 patent/US9217021B2/en active Active
- 2012-07-06 US US13/542,747 patent/US20130172235A1/en not_active Abandoned
-
2015
- 2015-11-16 US US14/942,307 patent/US9833495B2/en not_active Expired - Fee Related
-
2017
- 2017-01-20 JP JP2017008251A patent/JP6251827B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liang et al. | Therapeutic roles of polysaccharides from Dendrobium Officinaleon colitis and its underlying mechanisms | |
| JP2012502113A5 (enExample) | ||
| Tao et al. | Inhibition of Th1/Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin | |
| Wang et al. | Role of crosstalk between glial cells and immune cells in blood-brain barrier damage and protection after acute ischemic stroke | |
| Wang et al. | Targeting macrophage autophagy for inflammation resolution and tissue repair in inflammatory bowel disease | |
| Pham et al. | Strategies for the design of orally bioavailable antileishmanial treatments | |
| US10653669B2 (en) | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation | |
| EA201270167A1 (ru) | Лекарственная форма глатирамера ацетата с уменьшенным объемом и способы введения | |
| AR081948A2 (es) | USO DE b DEFENSINAS DE MAMIFEROS PARA LA MANUFACTURA DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS DEL INTESTINO | |
| JP2020516615A5 (enExample) | ||
| JP2013544244A5 (enExample) | ||
| JP2011520980A5 (enExample) | ||
| Sagnak et al. | Predictive Value of Urinary Interleukin-8 Cutoff Point for Recurrences After Transurethral Resection Plus Induction Bacillus Calmette-Guérin Treatment in Non–Muscle-Invasive Bladder Tumors | |
| US20210038696A1 (en) | Rectal insulin for treatment of inflammatory bowel diseases | |
| Goh et al. | Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine | |
| Khiong et al. | Inhibition of NF-κB pathway as the therapeutic potential of red fruit (Pandanus conoideus Lam.) in the treatment of inflammatory bowel disease | |
| WO2016150151A1 (zh) | 青蒿琥酯在制备治疗中晚期脓毒症药物中的运用 | |
| Belhadjali | Sweet's syndrome associated with multiple myeloma | |
| CN102488699A (zh) | 芍药苷在制备防治肺纤维化药物中的应用 | |
| Vaishnavi | Management of Recurrent Apthous stomatitis-A Review | |
| Gao et al. | Tripterygium wilfordii polyglycosidium ameliorates pouchitis induced by dextran sulfate sodium in rats | |
| Hong et al. | Annular leukocytoclastic vasculitis in a patient with ulcerative colitis | |
| Kurochkina et al. | Drug therapy of patients with myocardial infarction: medical appointments and patient adherence | |
| CN113209104B (zh) | Jak3抑制剂在制备治疗急性呼吸窘迫综合症药物中的应用 | |
| Fernandes et al. | Paradoxical skin reaction with infliximab treatment |